Biologic Therapies

Biologic Therapies is a class of pharmacologic interventions that employ complex, typically large-molecule products derived from or engineered in living systems—such as monoclonal antibodies, recombinant proteins, nucleic acid–based agents, or cellular products—to modulate specific molecular or cellular components of the immune system for therapeutic purposes.

489

Publications

22.1K

Citations

3K

Authors

1K

Institutions

Publications per year

2017–2026

175

Authors

3K

  1. BD
    Bruce D. Cheson

    Georgetown University, United States

    5 publications · 109 citations

    5

    h-index

  2. WG
    William G. Wierda

    The University of Texas MD Anderson Cancer Center, United States

    5 publications · 468 citations

    5

    h-index

  3. FG
    Fabio Garofolo

    Bristol-Myers Squibb (United States), United States

    5 publications · 124 citations

    5

    h-index

  4. LG
    Liam G. Heaney

    Queen's University Belfast, United Kingdom

    4 publications · 267 citations

    4

    h-index

  5. TJ
    Thomas J. Kipps

    University of California San Diego, United States

    4 publications · 456 citations

    4

    h-index

1–5 of 3K

Venues

  1. PubMed

    Repository · 54 publications · 1.3K citations

    22

    h-index

  2. Blood

    32 publications · 2.3K citations

    20

    h-index

  3. Nature Biotechnology

    10 publications · 552 citations

    10

    h-index

  4. 10

    h-index

  5. Clinical Therapeutics

    6 publications · 177 citations

    6

    h-index

1–5